Precigen Balance Sheet
NASDAQ: PGENHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Precigen financial position
At the end of fiscal 2025, Precigen reported total assets of $155.5 million, up 7.0% from a year earlier against total liabilities of $134.6 million. Shareholders' equity stood at $20.9 million, or 13.4% of assets. The company held $30.2 million in cash and equivalents against $93.2 million of debt, a net debt position of $62.9 million.
The current ratio (current assets divided by current liabilities) was 3.09, meaning short-term assets cover obligations due within a year. Debt-to-equity was 4.46.
Summary generated from market data by MetaCap's automated system. Methodology
Precigen balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 30.23M | 29.52M | 7.58M | 4.86M | 36.42M | 51.79M | 65.79M | 96.88M | 68.11M | 62.61M |
| Short-Term Investments | 67.62M | 68.39M | 55.28M | 51.09M | 72.24M | 48.33M | 9.26M | 119.61M | 6.27M | 174.60M |
| Receivables | 3.92M | 926.00K | 902.00K | 978.00K | 1.34M | 16.49M | 20.65M | 21.18M | 19.77M | 21.64M |
| Inventory | 9.58M | 0 | — | 287.00K | 326.00K | 11.36M | 16.10M | 20.57M | 20.49M | 21.14M |
| Total Current Assets | 115.23M | 102.41M | 68.75M | 118.16M | 156.63M | 148.95M | 234.64M | 285.48M | 154.05M | 315.18M |
| Property, Plant & Equipment | 13.76M | 13.83M | 7.11M | 7.33M | 8.60M | 34.92M | 43.95M | 86.90M | 112.67M | 64.67M |
| Goodwill | 15.23M | 19.14M | 26.61M | 36.92M | 37.55M | 54.36M | 54.12M | 93.63M | 93.75M | 157.18M |
| Intangible Assets | 3.18M | 4.46M | 40.70M | 44.45M | 52.29M | 65.40M | 68.35M | 88.96M | 232.88M | 225.62M |
| Long-Term Investments | 2.51M | 0 | — | 0 | 48.56M | 0 | — | — | — | — |
| Total Assets | 155.50M | 145.27M | 151.04M | 215.98M | 359.86M | 314.59M | 455.76M | 716.18M | 846.85M | 949.07M |
| Accounts Payable | 11.98M | 3.53M | 1.73M | 4.07M | 3.11M | 4.60M | 5.53M | 11.97M | 8.70M | 8.48M |
| Short-Term Debt | — | — | 0 | 86.44M | 52.00K | 360.00K | 31.67M | 479.00K | 502.00K | 386.00K |
| Total Current Liabilities | 37.31M | 21.52M | 22.98M | 78.64M | 34.65M | 42.13M | 122.91M | 61.56M | 80.17M | 94.61M |
| Long-Term Debt | 93.17M | 0 | — | 0 | 179.88M | 171.52M | 186.32M | 211.22M | 7.54M | 7.56M |
| Total Liabilities | 134.59M | 78.53M | 32.55M | 89.72M | 252.51M | 247.41M | 384.05M | 337.45M | 300.31M | 379.82M |
| Shareholders' Equity | 20.91M | 38.51M | 118.50M | 126.26M | 107.35M | 67.17M | 71.71M | 362.86M | 533.63M | 560.24M |
| Retained Earnings | -2.34B | -2.09B | -1.96B | -1.87B | -1.92B | -1.82B | -1.65B | -1.33B | -847.82M | -729.34M |
| Total Debt | 93.17M | 0 | 0 | 86.44M | 179.93M | 171.88M | 217.99M | 211.69M | 8.04M | 7.95M |
| Net Cash (Debt) | 4.68M | 97.91M | 62.85M | -30.49M | -71.27M | -71.77M | -142.94M | 4.79M | 66.35M | 229.26M |
| Shares Outstanding | 353.91M | 292.87M | 248.92M | 208.15M | 206.74M | 187.66M | 163.27M | 160.02M | 122.09M | 118.69M |
This table shows 10 annual periods of Precigen's balance sheet, from FY 2025 back to FY 2016, across 20 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow PGEN's reporting calendar. What is a balance sheet?